1. Home
  2. CLDX vs BLX Comparison

CLDX vs BLX Comparison

Compare CLDX & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • BLX
  • Stock Information
  • Founded
  • CLDX N/A
  • BLX 1977
  • Country
  • CLDX United States
  • BLX Panama
  • Employees
  • CLDX N/A
  • BLX 322
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BLX Commercial Banks
  • Sector
  • CLDX Health Care
  • BLX Finance
  • Exchange
  • CLDX Nasdaq
  • BLX Nasdaq
  • Market Cap
  • CLDX 1.4B
  • BLX 1.7B
  • IPO Year
  • CLDX 2008
  • BLX N/A
  • Fundamental
  • Price
  • CLDX $22.08
  • BLX $46.10
  • Analyst Decision
  • CLDX Strong Buy
  • BLX
  • Analyst Count
  • CLDX 9
  • BLX 0
  • Target Price
  • CLDX $46.13
  • BLX N/A
  • AVG Volume (30 Days)
  • CLDX 1.5M
  • BLX 114.8K
  • Earning Date
  • CLDX 08-07-2025
  • BLX 10-28-2025
  • Dividend Yield
  • CLDX N/A
  • BLX 5.40%
  • EPS Growth
  • CLDX N/A
  • BLX 12.91
  • EPS
  • CLDX N/A
  • BLX 5.97
  • Revenue
  • CLDX $5,790,000.00
  • BLX $306,166,000.00
  • Revenue This Year
  • CLDX N/A
  • BLX $15.00
  • Revenue Next Year
  • CLDX N/A
  • BLX $5.52
  • P/E Ratio
  • CLDX N/A
  • BLX $7.75
  • Revenue Growth
  • CLDX N/A
  • BLX 12.96
  • 52 Week Low
  • CLDX $14.40
  • BLX $29.78
  • 52 Week High
  • CLDX $47.00
  • BLX $47.43
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 47.99
  • BLX 62.48
  • Support Level
  • CLDX $21.34
  • BLX $45.62
  • Resistance Level
  • CLDX $23.27
  • BLX $46.29
  • Average True Range (ATR)
  • CLDX 1.54
  • BLX 0.85
  • MACD
  • CLDX -0.15
  • BLX 0.05
  • Stochastic Oscillator
  • CLDX 33.75
  • BLX 57.40

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.

Share on Social Networks: